Author:
S Thirunavukarasu,M Zaman,A Hayat,R Aghamohammadzadeh,N* Malik
Publisher
Heighten Science Publications Corporation
Reference14 articles.
1. 1. Resnic FS, Majithia A, Marinac-Dabic D, Robbins S, Ssemaganda H, et al. Registry-Based Prospective, Active Surveillance of Medical-Device Safety. N Engl J Med. 2017; 376: 526-535. Ref.: https://bit.ly/2Kp4Eqi
2. 2. Grandhi R, Kanaan H, Shah A, Harrison G, Bonfield C, et al. Safety and efficacy of percutaneous femoral artery access followed by Mynx closure in cerebral neurovascular procedures: a single center analysis. J Neurointerv Surg. 2014; 6: 445-450. Ref.: https://bit.ly/2WBabAz
3. 3. Taha A, Walsh EK, Wright KA, Ahmed I, Supakul N, et al. Safety and feasibility of a novel vascular closure device in neurointerventional procedures. Interv Neuroradiol. 2013; 19: 353-358. Ref.: https://bit.ly/2wyaX2v
4. 4. Baker NC, Escarcega RO, Lipinski MJ, Magalhaes MA, Koifman E, et al. Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis. J Interv Cardiol. 2016; 29: 108-112. Ref.: https://bit.ly/2WlFXlK
5. 5. Azmoon S, Pucillo AL, Aronow WS, Ebrahimi R, Vozzolo J, et al. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. J Invasive Cardiol. 2010; 22: 175-178. Ref.: https://bit.ly/2wFhOXP